EyePoint Pharmaceuticals
EYPT
#5187
Rank
A$2.27 B
Marketcap
A$27.47
Share price
2.62%
Change (1 day)
98.62%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.30 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has A$0.30 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.54 B38.4%
2023-12-31$A$0.39 B176.04%
2022-12-31$A$0.14 B-44.32%
2021-12-31$A$0.25 B954.73%
2020-12-31$A$24.11 M102.67%
2019-12-31$A$11.89 M
2018-06-30$A$15.78 M-9.11%
2017-06-30$A$17.36 M-38.04%
2016-06-30$A$28.03 M-7.7%
2015-06-30$A$30.37 M91.9%
2014-06-30$A$15.82 M87.64%
2013-06-30$A$8.43 M-36.65%
2012-06-30$A$13.31 M-61.88%
2011-06-30$A$34.92 M-10.47%
2010-06-30$A$39 M34.05%
2009-06-30$A$29.09 M-7.47%
2008-06-30$A$31.44 M-68.13%
2007-06-30$A$98.67 M-43.84%
2006-06-30$A$0.17 B121.52%
2005-06-30$A$79.31 M105.13%
2004-06-30$A$38.66 M510.17%
2003-06-30$A$6.33 M
2001-06-30$A$8.93 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
A$21.59 M-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-A$4.35 Million-101.44% Bahamas